Track 1: | Introduction |
Track 2: | Management of metastatic melanoma with BRAF mutation |
Track 3: | Case from the community |
Track 4: | Adjuvant and neoadjuvant treatment |
Track 5: | Current and future use of checkpoint inhibition |
FACULTY |
Michael B Atkins, MD Deputy Director Georgetown Lombardi Comprehensive Cancer Center William M Scholl Professor and Vice-Chair, Department of Oncology Professor of Medicine Georgetown University Medical Center Washington, DC |
Professor Georgina Long, AO, BSc, PhD, MBBS Co-Medical Director of Melanoma Institute Australia Chair of Melanoma Medical Oncology and Translational Research Melanoma Institute Australia and Royal North Shore Hospital The University of Sydney Sydney, Australia |
Jason J Luke, MD Associate Professor and Director of the Cancer Immunotherapeutics Center University of Pittsburgh Medical Center and Hillman Cancer Center Pittsburgh, Pennsylvania |
MODERATOR |
Neil Love, MD Research To Practice Miami, Florida |